首页> 外文期刊>Journal of immunology research. >TNPO1-Mediated Nuclear Import of FUBP1 Contributes to Tumor Immune Evasion by Increasing NRP1 Expression in Cervical Cancer
【24h】

TNPO1-Mediated Nuclear Import of FUBP1 Contributes to Tumor Immune Evasion by Increasing NRP1 Expression in Cervical Cancer

机译:TNPO1介导的FUBP1核导入通过增加宫颈癌中的NRP1表达来有助于肿瘤免疫逃避

获取原文
           

摘要

Far upstream element binding protein 1 (FUBP1), a DNA-binding protein, participates in diverse tumor-promoting behaviors by regulating the expression of oncogenes in the nucleus, but the underlying mechanisms remain to be elucidated. In the present study, we found that FUBP1 mRNA and protein expressions were markedly upregulated and closely linked with poor prognosis in cervical cancer. In vitro , functional experiments showed that knockdown of FUBP1 inhibited CC cell proliferation and migration. Therefore, FUBP1 plays a prooncogenic function in CC progression. Further investigations for the first time demonstrated that nuclear localization of FUBP1 regulated the gene expression of immune checkpoint NRP1. Moreover, our work demonstrated that FUBP1 translocated into the nucleus which was mediated by interacting with Transportin-1 (TNPO1). Collectively, this study revealed that FUBP1 might be a potential therapeutic target for the restriction of tumor progression.
机译:远程元素结合蛋白1(FUBP1),DNA结合蛋白,通过调节细胞核中的癌基因的表达,但仍然阐明潜在机制。 在本研究中,我们发现FUBP1 mRNA和蛋白质表达明显上调并与宫颈癌的预后不良密切相关。 在体外,功能实验表明,FUBP1的敲低抑制了CC细胞增殖和迁移。 因此,FUBP1在CC进展中发挥了前易化的功能。 第一次进一步调查表明,FUBP1的核定位调节了免疫检查点NRP1的基因表达。 此外,我们的工作表明,通过与转运-1(TNPO1)相互作用而旋转到核的核心的FUBP1。 集体,本研究表明,FUBP1可能是限制肿瘤进展的潜在治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号